BeOne Medicines Ltd. (ONC) 当前追踪市盈率 (P/E) 为 177.5, 前瞻市盈率为 50.9. 追踪盈利收益率为 0.56%, 前瞻盈利收益率 1.96%. PEG 1.51. 格雷厄姆数为 $3.70.
本页证实的标准:
SharesGrow 综合评分： 66/100 其中 4/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -7.9 | -0.07 | 2.67 | 880.94 | - |
| 2017 | -45.2 | 1.04 | 6.16 | 17.67 | - |
| 2018 | -11.5 | -0.03 | 4.43 | 39.23 | - |
| 2019 | -10.5 | -0.34 | 10.35 | 23.25 | - |
| 2020 | -13.3 | -0.65 | 5.57 | 69.83 | - |
| 2021 | -17.2 | 0.84 | 4.10 | 21.37 | - |
| 2022 | -11.3 | -0.41 | 5.17 | 16.02 | - |
| 2023 | -21.0 | 0.37 | 5.22 | 7.51 | - |
| 2024 | -30.2 | 1.09 | 5.84 | 5.10 | - |
| 2025 | 115.5 | -0.18 | 7.60 | 6.20 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-3.90 | $1.07M | $-119.22M | -11141.8% |
| 2017 | $-2.21 | $238.39M | $-93.11M | -39.1% |
| 2018 | $-12.09 | $198.22M | $-673.77M | -339.9% |
| 2019 | $-15.86 | $428.21M | $-950.58M | -222% |
| 2020 | $-19.11 | $308.87M | $-1.6B | -518.2% |
| 2021 | $-15.21 | $1.18B | $-1.41B | -120.2% |
| 2022 | $-19.37 | $1.42B | $-2B | -141.5% |
| 2023 | $-8.45 | $2.46B | $-881.71M | -35.9% |
| 2024 | $-6.12 | $3.81B | $-644.79M | -16.9% |
| 2025 | $32.89 | $5.34B | $286.93M | 5.4% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $6.08 | $5.17 – $6.77 | $6.4B | $6.37B – $6.48B | 11 |
| 2027 | $9.55 | $6.04 – $12.97 | $7.42B | $7.19B – $7.73B | 12 |
| 2028 | $12.93 | $8.18 – $18.18 | $8.34B | $8.27B – $8.41B | 10 |
| 2029 | $16.17 | $15.37 – $17.26 | $9.27B | $8.92B – $9.75B | 4 |
| 2030 | $19.49 | $18.53 – $20.80 | $10.41B | $10.01B – $10.95B | 4 |
